blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3371602

EP3371602 - A METHOD FOR QUANTIFYING ANTI-TNF ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  02.08.2019
FormerGrant of patent is intended
Status updated on  18.03.2019
FormerRequest for examination was made
Status updated on  10.08.2018
FormerThe international publication has been made
Status updated on  13.05.2017
Formerunknown
Status updated on  18.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Promise Proteomics
7 Parvis Louis Néel
Bht 52A
CS 20050
38040 Grenoble cedex 9 / FR
[2019/36]
Former [2018/37]For all designated states
Promise Advanced Proteomics
7 Parvis Louis Neel
CS20050
38040 Grenoble Cedex 9 / FR
Inventor(s)01 / LEBERT, Dorothée
32 chemin des olagnères
38450 Le Gua / FR
02 / PICARD, Guillaume
90 chemin de Culaz
74130 Mont-Saxonnex / FR
 [2018/37]
Representative(s)Cabinet Nony
11 rue Saint-Georges
75009 Paris / FR
[N/P]
Former [2018/37]Nony
11 rue Saint-Georges
75009 Paris / FR
Application number, filing date16791588.304.11.2016
[2018/37]
WO2016EP76739
Priority number, dateWO2015EP30675906.11.2015         Original published format: PCT/EP2015/306759
[2018/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017077080
Date:11.05.2017
Language:EN
[2017/19]
Type: A1 Application with search report 
No.:EP3371602
Date:12.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2017 takes the place of the publication of the European patent application.
[2018/37]
Type: B1 Patent specification 
No.:EP3371602
Date:04.09.2019
Language:EN
[2019/36]
Search report(s)International search report - published on:EP11.05.2017
ClassificationIPC:G01N33/68
[2018/37]
CPC:
G01N33/6848 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/37]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR QUANTIFIZIERUNG VON ANTI-TNF-ANTIKÖRPERN[2018/37]
English:A METHOD FOR QUANTIFYING ANTI-TNF ANTIBODIES[2018/37]
French:PROCÉDÉ DE QUANTIFICATION D'ANTICORPS ANTI-TNF[2018/37]
Entry into regional phase06.06.2018National basic fee paid 
06.06.2018Designation fee(s) paid 
06.06.2018Examination fee paid 
Examination procedure03.05.2018Date on which the examining division has become responsible
06.06.2018Examination requested  [2018/37]
18.12.2018Amendment by applicant (claims and/or description)
19.03.2019Communication of intention to grant the patent
23.07.2019Fee for grant paid
23.07.2019Fee for publishing/printing paid
23.07.2019Receipt of the translation of the claim(s)
Opposition(s)05.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
30.11.2018Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.11.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MK04.09.2019
MT04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
[2022/32]
Former [2022/27]HU04.11.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2021/34]HU04.11.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2021/33]HU04.11.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2021/26]AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/46]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
IE04.11.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/37]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/36]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/35]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
LU04.11.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/34]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
CH30.11.2019
LI30.11.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/27]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/25]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/23]AL04.09.2019
AT04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/22]AL04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/15]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/12]FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/10]FI04.09.2019
LT04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
Former [2020/09]FI04.09.2019
LT04.09.2019
NO04.12.2019
Former [2020/08]LT04.09.2019
NO04.12.2019
Cited inInternational search[A]WO2006131013  (ESBATECH AG [CH], et al) [A] 1-15 * abstract *;
 [A]WO2011056590  (PROMETHEUS LAB INC [US], et al) [A] 1-15 * abstract *;
 [A]  - Bendtzen K and Svenson M, "Enzyme Immunoassays and Radioimmunoassays for Quantification of Anti-TNF Biopharmaceuticals and Anti-Drug Antibodies", Bendtzen K and Svenson M, Tovey MG, Detection and Quantification of Antibodies to biopharmaceuticals: Practical and Applied Considerations, John Wiley and Sons Inc, (20110620), pages 82 - 101, III, doi:10.1002/9781118075685.ch5, ISBN 9781118075685, XP002754673 [A] 1-15 * p 86, paras 5.3.1. and 5.3.1.1. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.